In silico analyses of COMT, an important signaling cascade of dopaminergic neurotransmission pathway, for drug development of Parkinson's disease

Applied Biochemistry and Biotechnology

Volumn 167, Issue 4, 2012, Pages 845-860

  Chakraborty, Chiranjib ^a   Pal, Soumen ^a   Doss, C George Priya ^a   Wen, Zhi Hong ^b   Lin, Chan Shing ^b  

^a VIT UNIVERSITY   (India)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Catechol O methyltransferase; Dopaminergic neurotransmitter; In silico analysis; Parkinson's disease

Indexed keywords

AMINO ACID COMPOSITIONS; BINDING POCKETS; CATECHOL-O-METHYLTRANSFERASE; DISULFIDE BONDS; DOPAMINERGIC NEUROTRANSMITTER; DRUG DEVELOPMENT; EVOLUTIONARY RELATIONSHIPS; GENOMICS; GENOMICS ANALYSIS; HYDROPHOBIC SEGMENT; IN-SILICO; PARKINSON'S DISEASE; PHYLOGENETIC TREES; PHYSICAL HEALTH; PROTEOMICS; SIGNALING CASCADES; TRANSMEMBRANE SEGMENTS;

AMINES; AMINO ACIDS; COVALENT BONDS; DEGRADATION; GENES; MAMMALS; MOLECULAR BIOLOGY; NEURODEGENERATIVE DISEASES; PHENOLS;

NEUROPHYSIOLOGY;

3,4 DIHYDROXYPHENYLACETIC ACID; ANTIPARKINSON AGENT; CATECHOL METHYLTRANSFERASE; CATECHOL METHYLTRANSFERASE INHIBITOR; CYSTEINE; DOPAMINE; ENTACAPONE; HOMOVANILLIC ACID; LEVODOPA; NEUROTRANSMITTER; TOLCAPONE;

AMINO ACID SEQUENCE; ARTICLE; CHROMOSOME 22; CODON; COMPUTER MODEL; DISULFIDE BOND; DOPAMINE METABOLISM; DOPAMINERGIC TRANSMISSION; DRUG RESEARCH; DRUG TARGETING; DYSKINESIA; ENZYME INHIBITION; ENZYME STRUCTURE; GENE SEQUENCE; GENOMICS; HUMAN; MOUSE; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PHYLOGENETIC TREE; PREDICTION; PROTEIN SECONDARY STRUCTURE; PROTEOMICS; RAT; SPECIES COMPARISON; STRUCTURE ANALYSIS; TANDEM REPEAT;

AMINO ACID SEQUENCE; ANIMALS; CATECHOL O-METHYLTRANSFERASE; CELL MEMBRANE; CODON; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; DISULFIDES; DOPAMINERGIC NEURONS; DRUG DISCOVERY; EVOLUTION, MOLECULAR; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PARKINSON DISEASE; PHYLOGENY; PROTEIN STRUCTURE, SECONDARY; SURFACE PROPERTIES; SYNAPTIC TRANSMISSION;

AMPHIBIA; MAMMALIA; PISCES;

EID: 84863725024     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-012-9725-5     Document Type: Article

References (66)

1. Dauer, W., & Przedborski, S. (2003). Neuron, 39, 889-909.
2. Hornykiewicz, O. (1970). Rivista di Patologia Nervosa e Mentale, 91, 281-286.
3. Gold, B. G., & Nutt, J. G. (2002). Current Opinion in Pharmacology, 2,82-86.
4. Matsumoto, M., Weickert, C. S., Akil, M., Lipska, B. K., Hyde, T. M., Herman, M. M., Kleinman, J. E., & Weinberger, D. R. (2003). Neuroscience, 116, 127-137.
5. Brooks, D. J. (2001). Journal of Neural Transmission, 108, 1283-1298.
6. Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D. K., Ischiropoulos, H., & Przedborski, S. (2002). Journal of Neuroscience, 22, 1763-1771.
7. Olanov, C. W., Schapira, A. H., & Agid, Y. (2003). Annals of Neurology, 53, S1-S2.
8. Serra, P. A., Esposito, G., Enrico, P., Mura, M. A., Migheli, R., et al. (2000). British Journal of Pharmacology, 130, 937-945.
9. Werner, P., Mytilineou, C., Cohen, G., & Yahr, M. D. (1994). European Journal of Pharmacology, 263, 157-162.
10. Nutt, J. G. (1990). Neurology, 40, 340-345.
11. Sulzer, D., Bogulavsky, J., Larsen, K. E., Behr, G., Karatekin, E., et al. Proceedings of the National Academy of Sciences of the United States of America, 97, 1869-1874
12. Graham, D. G. (1978). Molecular Pharmacology, 14, 633-643.
13. Hald, A., & Lotharius, J. (2005). Experimental Neurology, 193, 279-290.
14. Zhou, C., Huang, Y., & Przedborski, S. (2008). Annals of the New York Academy of Sciences, 1147,93-104.
15. Melnikova, V. I., Lavrenteva, A. V., Kudrin, V. S., Raevskii, K. S., & Ugryumov, M. V. (2005). Neuroscience and Behavioral Physiology, 35, 809-813
16. Molinoff, P. B., & Axelrod, J. (1971). Annual Review of Biochemistry, 40, 465-500
17. Mannisto, P. T., Ulmanen, I., Lundstrom, K., Taskinen, J., Tenhunen, J., Tilgman, C., & Kaakkola, S. (1992). Progress in Drug Research, 39, 291-348
18. Westerink, B. H. C. (1985). Neurochemistry International, 7, 221-227
19. Bortolato, M., Chen, K., & Shih, J. C. (2008). Advanced Drug Delivery Reviews, 60, 1527-1533
20. Mannisto, P. T., & Kaakkola, S. (1999). Pharmacological Reviews, 51, 593-628
21. Raevskii, K. S., Gainetdinov, R. R., Budygin, E. A., Mannisto, P., & Wightman, M. Neuroscience and Behavioral Physiology, 32, 183-188
22. Okereke, C. S. (2002). Journal of Pharmacy and Pharmaceutical Sciences, 5, 146-161
23. Rinne, U. K., Larsen, J. P., Siden, A., & Worm-Petersen, J. (1998). Neurology, 51, 1309-1314
24. Rajput, A. H., Martin, W., Saint-Hillaire, M. H., Dorflinger, E., & Pedder, S. Neurology, 49, 1066-1071
25. Lees, A. J. (2008). CNS Neuroscience and Therapeutics, 14,83-93
26. Muto, A., & Osawa, S. (1987). Proceedings of the National Academy of Sciences of the United States of America, 84, 166-169
27. Yakovchuk, P., Protozanova, E., & Frank-Kamenetskii, M. D. (2006). Nucleic Acids Research, 34, 564-574
28. Jermiin, L. S., Graur, D., Lowe, R. M., & Crozier, R. H. Journal of Molecular Evolution, 39, 160-173
29. Hashimoto, T., Nakamura, Y., Nakamura, F., Shirakura, T., Adachi, J., Goto, N., Okamoto, K., & Hasegawa, M. (1994). Molecular and Biological Evolution, 11,65-71
30. Zeeberg, B. (2002). Genome Research, 12, 944-955
31. Tao, X., & Dafu, D. (1998). FEBS Letters, 434,93-96
32. Sayers, E. W., Barrett, T., Benson, D. A., Bolton, E., Bryant, S. H., et al. (2011). Nucleic Acids Research, 39, D38-D51.
33. Leavitt, A., Chmelnitskym, I., Carmeli, Y., & Navon-Venezia, S. Antimicrobial Agents and Chemotherapy, 54, 4493-4496
34. Brendel, V., Bucher, P., Nourbakhsh, I., Blaisdell, B. E., & Karlin, S. (2002). Proceedings of the National Academy of Sciences of the United States of America, 89, 2002-2006
35. Cheng, J., Randall, A. Z., Sweredoski, M. J., & Baldi, P. (2005). Nucleic Acids Research, 33, W72-W76
36. Herraez, A. (2006). Biochemistry and Molecular Biology Education, 34, 255-261
37. Hanson, R. M. (2010). Journal of Applied Crystallography, 43, 1250-1260
38. DeLano, W. L. (2002). The PyMOL molecular graphics System.
39. Ashkenazy, H., Erez, E., Martz, E., Pupko, T., & Ben-Tal, N. (2010). Nucleic Acids Research, 38, W529-W533
40. Glaser, F., Pupko, T., Paz, I., Bell, R. E., Bechor-Shental, D., Martz, E., & Ben-Tal, N. (2003). Bioinformatics, 19, 163-164
41. Tseng, Y. Y., Chen, Z. J., & Li, W. H. (2010). Nucleic Acids Research, 38, D288-D295
42. Smith, T. F., & Waterman, M. S. (1981). Journal of Molecular Biology, 147, 195-197
43. Tseng, Y. Y., Dupree, C., Chen, Z. J., & Li, W. H. (2009). Nucleic Acids Research, 37, W384-W389.
44. Schneider, T. D. & Stephens, R. M. Nucleic Acids Res, 18, 6097-6100
45. Crooks, G. E., Hon, G., Chandonia, J. M., & Brenner, S. E. (2004). Genome Research, 14, 1188-1190
46. Dereeper, A., Guignon, V., Blanc, G., Audic, S., Buffet, S., Chevenet, F., Dufayard, J. F., Guindon, S., Lefort, V., Lescot, M., & Claverie, J. M. (2008). Nucleic Acids Research, 36, W465-W469
47. Axelrod, J., Senoh, S., & Witkop, B. (1958). O-methylation of catechol amines in vivo. Journal of Biological Chemistry, 233, 697-701.
48. Axelrod, J., & Tomchick, R. (1958). Journal of Biological Chemistry, 233, 702-705
49. Guldberg, H. C., & Marsden, C. A. (1975). Pharmacological Reviews, 27, 135-206
50. Mannisto, P. T., & Kaakkola, S. (1989). Trends in Pharmacological Sciences, 10,54-56
51. Mannisto, P. T., & Kaakkola, S. (1990). Pharmacology and Toxicology, 66, 317-323
52. Dingemanse, J. (1997). Drug Development Research, 42,1-25
53. Purushotham, D., Ganguly, C., & Chakraborty, C. (2011). Letters in Drug Design & Discovery, 8, 246-252
54. Grossman, M. H., Emanuel, B. S., & Budarf, M. L. (1992). Genomics, 12, 822-825
55. Winqvist, R., Lundstrom, K., Salminen, M., Laatikainen, M., & Ulmanen, I. (1992). Cytogenetics and Cell Genetics, 59, 253-257
56. Salminen, M., Lundstrom, K., Tilgmann, C., Savolainen, R., Kalkkinen, N., & Ulmanen, I. (1990). Gene, 93, 241-247
57. Lundstrom, K., Salminen, M., Jalanko, A., Savolainen, R., & Ulmanen, I. (1991). DNA and Cell Biology, 10, 181-189
58. Rutherford, K., Le Trong, I., Stenkamp, R. E., & Parson, W. W. (2008). Journal of Molecular Biology, 380, 120-130
59. Malherbe, P., Bertocci, B., Caspers, P., Zurcher, G., & Da Prada, M. (1992). Journal of Neurochemistry, 58, 1782-1789
60. Vidgren, J., Ovaska, M., Tenhunen, J., Tilgmann, C., Lotta, T., & Mannisto, P. T. (1999). In X. Cheng & R. M. Blumenthal (Eds.), Structure and function of AdoMet-dependent methyltransferases (pp. 55-91). Singapore: World Scientific.
61. Vidgren, J., Svensson, L. A., & Liljas, A. (1994). Nature, 368, 354-358
62. Vidgren, J., Tilgmann, C., Lundstrom, K., & Liljas, A. (1991). Proteins: Structure, Function, and Genetics, 11, 233-236
63. Vidgren, J., & Ovaska, M. (1997). In P. Veerapandian (Ed.), Structure-based drug design (pp. 343-363). New York: Marcel Dekker, Inc.
64. Deo, N. (1974). Prentice Hall Series in Automatic Computation.
65. Mittal, R., Jain, B. N., & Patney, R. K. (1994). Microelectronics Reliability, 34, 1301-1310.
66. Chakraborty, C., Agoramoorthy, G., & Hsu, M. J. (2011). PLoS One, 6, e16580.